Ceritinib—a second-generation ALK inhibitor overcoming resistance in ALK-rearranged non-small cell lung cancer

類似資料

• The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer
  著者:: Friboulet, Luc, 等
  出版事項: (2014)
• Elucidation of Resistance Mechanisms to Second-Generation ALK Inhibitors Alectinib and Ceritinib in Non–Small Cell Lung Cancer Cells
  著者:: Dong, Xuyuan, 等
  出版事項: (2016)
• Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer
  著者:: Shaw, Alice T., 等
  出版事項: (2014)
• Ceritinib for ALK-Rearrangement–Positive Non–Small Cell Lung Cancer
  著者:: Nix, Nancy M., 等
  出版事項: (2015)
• New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib
  著者:: Rothschild, Sacha I
  出版事項: (2016)